Shanghai ChemPartner (ChemPartner), a wholly-owned subsidiary of ShangPharma, has extended its drug discovery collaboration with Elara. ChemPartner will provide fully integrated services in the areas of DMPK, pharmacology
Nile has reported the dosing of its first patient in a phase 2 clinical study of its lead product, CD-NP, for the treatment of acute heart failure. The
Samarion has entered into an agreement with Nebraska-based Adesta, for the nationwide installation of the SamarionSolution in long-term care and acute care facilities. The SamarionSolution is an improvement
DARA BioSciences is collaborating with America Stem Cell (ASC) to expand on observations from recent preclinical studies. The results showed that dipeptidylpeptidase (DPPIV) inhibitors has improved the efficiency
Amgen and Wyeth have issued a statement in response to the FDA announcement regarding the results of a safety review of Tumor Necrosis Factor (TNF) blockers. TNF blocker
Impax Laboratories has reported net income of $3 million, or $0.05 per diluted share for the second quarter of 2009, as compared to $17.1 million for the prior
Laboratory Corporation of America (LabCorp) has completed the acquisition of Monogram Biosciences (Monogram). LabCorp acquired Monogram pursuant to a cash tender offer, followed by the merger of a
Aphios has received a phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH). The fund
Chemizon has reported that Takeda will continue, and further expand its current research collaboration that utilizes Chemizon’s Discovery Platform. The expansion will be effective beginning the 1st of
DOR has received FDA’s Orphan Drug Designation for Oral BDP (beclomethasone 17,21 dipropionate, or orBec). It is meant for the treatment of gastrointestinal (GI) symptoms associated with chronic
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.